Double Medical Technology Inc (002901) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.060x

Based on the latest financial reports, Double Medical Technology Inc (002901) has a cash flow conversion efficiency ratio of 0.060x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥207.34 Million ≈ $30.34 Million USD) by net assets (CN¥3.44 Billion ≈ $503.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002901 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Double Medical Technology Inc - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Double Medical Technology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Double Medical Technology Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Double Medical Technology Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Anhui Wanwei Updated High-tech Material Industry Co Ltd
SHG:600063
0.005x
Quaker Chemical Corporation
NYSE:KWR
0.003x
Central Puerto S.A.
BA:CEPU
0.014x
Fraser Neave Holdings Bhd
KLSE:3689
0.037x
Petrosea Tbk
JK:PTRO
-0.024x
Voltronic Power Technology Corp
TW:6409
0.046x
DHT Holdings Inc
NYSE:DHT
0.064x
Suzhou Nanomicro Technology Co Ltd
SHG:688690
0.014x

Annual Cash Flow Conversion Efficiency for Double Medical Technology Inc (2013–2025)

The table below shows the annual cash flow conversion efficiency of Double Medical Technology Inc from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see 002901 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.69 Billion
≈ $539.27 Million
CN¥831.34 Million
≈ $121.65 Million
0.226x +62.27%
2024-12-31 CN¥3.18 Billion
≈ $465.57 Million
CN¥442.30 Million
≈ $64.72 Million
0.139x +494.63%
2023-12-31 CN¥3.16 Billion
≈ $462.50 Million
CN¥73.89 Million
≈ $10.81 Million
0.023x -43.46%
2022-12-31 CN¥3.11 Billion
≈ $454.56 Million
CN¥128.44 Million
≈ $18.80 Million
0.041x -84.10%
2021-12-31 CN¥2.59 Billion
≈ $378.76 Million
CN¥673.26 Million
≈ $98.52 Million
0.260x -0.13%
2020-12-31 CN¥2.13 Billion
≈ $312.26 Million
CN¥555.77 Million
≈ $81.33 Million
0.260x +5.26%
2019-12-31 CN¥1.75 Billion
≈ $256.59 Million
CN¥433.88 Million
≈ $63.49 Million
0.247x +7.72%
2018-12-31 CN¥1.46 Billion
≈ $213.33 Million
CN¥334.88 Million
≈ $49.00 Million
0.230x -7.84%
2017-12-31 CN¥1.24 Billion
≈ $181.24 Million
CN¥308.70 Million
≈ $45.17 Million
0.249x -30.19%
2016-12-31 CN¥580.13 Million
≈ $84.89 Million
CN¥207.13 Million
≈ $30.31 Million
0.357x +27.78%
2015-12-31 CN¥441.78 Million
≈ $64.65 Million
CN¥123.44 Million
≈ $18.06 Million
0.279x -49.27%
2014-12-31 CN¥274.36 Million
≈ $40.15 Million
CN¥151.12 Million
≈ $22.11 Million
0.551x +16.16%
2013-12-31 CN¥224.61 Million
≈ $32.87 Million
CN¥106.51 Million
≈ $15.59 Million
0.474x --

About Double Medical Technology Inc

SHE:002901 China Medical Devices
Market Cap
$2.56 Billion
CN¥17.50 Billion CNY
Market Cap Rank
#5522 Global
#1090 in China
Share Price
CN¥42.27
Change (1 day)
+1.51%
52-Week Range
CN¥35.38 - CN¥62.68
All Time High
CN¥114.55
About

Double Medical Technology Inc. engages in the research, development, production, and sale of high-value medical consumables in China. The company offers orthopedic trauma implants, spinal implants, joint implants, sports medicine and neurosurgery implants, minimally invasive surgical implants, and dental implants. It also exports its products. The company was formerly known as Xiamen Da Bo Ying J… Read more